Recombinant adenoviral expression of dominant negative IκBα protects brain from cerebral ischemic injury
- 22 November 2002
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 299 (1), 14-17
- https://doi.org/10.1016/s0006-291x(02)02573-1
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Significant Neuroprotection against Ischemic Brain Injury by Inhibition of the MEK1 Protein Kinase in Mice: Exploration of Potential Mechanism Associated with ApoptosisJournal of Pharmacology and Experimental Therapeutics, 2003
- The NF-κB inhibitor diethyldithiocarbamate (DDTC) increases brain cell death in a transient middle cerebral artery occlusion model of ischemiaBrain Research Bulletin, 2001
- Use of Suppression Subtractive Hybridization for Differential Gene Expression in StrokeStroke, 2001
- Inflammation and Stroke: Putative Role for Cytokines, Adhesion Molecules and iNOS in Brain Response to IschemiaBrain Pathology, 2000
- RelB Modulation of IκBα Stability as a Mechanism of Transcription Suppression of Interleukin-1α (IL-1α), IL-1β, and Tumor Necrosis Factor Alpha in FibroblastsMolecular and Cellular Biology, 1999
- In utero gene therapy: The case forNature Medicine, 1999
- IκB–NF-κB StructuresCell, 1998
- NF-kB: a crucial transcription factor for glial and neuronal cell functionTrends in Neurosciences, 1997
- Suppression of TNF-α-Induced Apoptosis by NF-κBScience, 1996
- NF-κB: Ten Years AfterCell, 1996